Cambiar Investors LLC Has $15.45 Million Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Cambiar Investors LLC lowered its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 0.7% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 188,745 shares of the company’s stock after selling 1,286 shares during the period. Cambiar Investors LLC owned approximately 0.22% of HealthEquity worth $15,449,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of HealthEquity by 1.7% in the first quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company’s stock valued at $715,783,000 after purchasing an additional 149,133 shares during the last quarter. Lisanti Capital Growth LLC bought a new position in shares of HealthEquity during the 1st quarter worth approximately $4,701,000. Sei Investments Co. lifted its position in shares of HealthEquity by 2.3% during the 1st quarter. Sei Investments Co. now owns 570,051 shares of the company’s stock worth $46,533,000 after buying an additional 12,958 shares in the last quarter. Vaughan Nelson Investment Management L.P. boosted its stake in shares of HealthEquity by 1.8% in the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 616,860 shares of the company’s stock worth $53,173,000 after buying an additional 11,150 shares during the last quarter. Finally, Choreo LLC bought a new position in shares of HealthEquity in the first quarter valued at approximately $1,041,000. 99.55% of the stock is owned by institutional investors.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now owns 54,719 shares of the company’s stock, valued at $4,540,582.62. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the transaction, the director now owns 54,719 shares of the company’s stock, valued at $4,540,582.62. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Frank Corvino sold 1,247 shares of the firm’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the sale, the director now owns 4,823 shares in the company, valued at approximately $387,093.98. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is owned by corporate insiders.

HealthEquity Trading Up 1.3 %

Shares of HealthEquity stock opened at $86.33 on Friday. The company’s 50-day moving average price is $81.24 and its 200-day moving average price is $79.92. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 12-month low of $61.81 and a 12-month high of $89.23. The company has a market cap of $7.54 billion, a price-to-earnings ratio of 71.94, a PEG ratio of 1.35 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.16. The business had revenue of $299.93 million for the quarter, compared to analysts’ expectations of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. On average, equities analysts expect that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on HQY. Bank of America cut their price target on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft increased their target price on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Barrington Research reaffirmed an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a report on Friday, September 20th. Royal Bank of Canada reissued an “outperform” rating and issued a $92.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Finally, JMP Securities reiterated a “market outperform” rating and set a $105.00 price target on shares of HealthEquity in a research note on Wednesday, September 4th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $103.83.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.